Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03753516 · ClinicalTrials.gov registry record · NA

Pelvic Floor Support After Laparoscopic Hysterectomy for Benign Conditions: A Randomized Controlled Trial Comparing Vaginal Cuff Closure Techniques

A NA study, sponsored by Walter Reed National Military Medical Center.

Terminated
Registry status
NA
Development phase
58
Enrollment target

NCT03753516: Clinical Trial NA study, sponsored by Walter Reed National Military Medical Center.

NCT03753516 is a NA study that was terminated before completion, run by Walter Reed National Military Medical Center. The registered enrollment target is 58 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03753516, a NA study, was terminated before completion, sponsored by Walter Reed National Military Medical Center.

TERMINATED
Registry status
NA
Development phase
58 participants
Enrollment target

Study Summary

The purpose of this study is to learn about the effect of different vaginal cuff closure techniques on pelvic support after laparoscopic hysterectomy and robotic assisted laparoscopic hysterectomy for benign gynecologic conditions.

Primary Outcome

The Pelvic Organ Prolapse - Quantification system is a validated way to measure pelvic organ prolapse. The investigators will measure this post op at 6-8 weeks to see if prolapse is better using one method vs the other.

Interventions

  • PROCEDURE Laparoscopic - Vaginal Cuff Closure
  • PROCEDURE Vaginal- Vaginal Cuff Closure

Trial Details

FieldValue
Enrollment Target 58 participants
Start Date 2017-07-01
Est. Completion 2020-12-30
Phase NA

Why NCT03753516 stopped before completion

NCT03753516 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Laparoscopic - Vaginal Cuff Closure is the first listed.

NCT03753516 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03753516 about?

NCT03753516 is a clinical study titled "Pelvic Floor Support After Laparoscopic Hysterectomy for Benign Conditions: A Randomized Controlled Trial Comparing Vaginal Cuff Closure Techniques". The purpose of this study is to learn about the effect of different vaginal cuff closure techniques on pelvic support after laparoscopic hysterectomy and robotic assisted laparoscopic hysterectomy for benign gynecologic conditions.

What is the current status of trial NCT03753516?

This trial is currently terminated. It is a NA study. The enrollment target is 58 participants. The study started on 2017-07-01. Estimated completion is 2020-12-30.

What interventions are being tested in trial NCT03753516?

The interventions under investigation include: Laparoscopic - Vaginal Cuff Closure (PROCEDURE), Vaginal- Vaginal Cuff Closure (PROCEDURE).

Who is sponsoring clinical trial NCT03753516?

This trial is sponsored by Walter Reed National Military Medical Center, which has 48 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03753516's enrollment target sits among peer trials

58 1256th of 2000 higher than 740 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03587844 · 58 participants · Phase 2

    Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

  • NCT03630991 · 58 participants · Phase 1

    Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

  • NCT03949855 · 58 participants · Phase 2

    Belimumab With Rituximab for Primary Membranous Nephropathy

  • NCT04069273 · 58 participants · Phase 2

    Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03753516, the US trial registry maintained by the National Library of Medicine. NCT03753516 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.